Innovative Clinical Research Institute - Oncology

Whittier, California 90602

0 studies enrolling now · 1 studies all time

What they study most

Lung Cancer, Metastatic Non-Small Cell Lung Cancer, NSCLC

Studies at this site

• Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Docetaxel for Metastatic Non-Small Cell Lung Cancer (NSCLC) (PRESERVE 4) — Stopped early